Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0159 Transporter Info
Gene Name	SLC23A2
Transporter Name	Sodium-dependent vitamin C transporter 2
Gene ID	9962
UniProt ID	Q9UGH3

Post-Translational Modification of This DT
Overview of SLC23A2 Modification Sites with Functional and Structural Information
Sequence	M M G I G K N T T S K S M E A G S S T E G K Y E D E A K H P A F F T L P V V I N G G A T S S G E Q D N E D T E L M A I Y T T E N G I A E K S S L A E T L D S T G S L D P Q R S D M I Y T I E D V P P W Y L C I F L G L Q H Y L T C F S G T I A V P F L L A D A M C V G Y D Q W A T S Q L I G T I F F C V G I T T L L Q T T F G C R L P L F Q A S A F A F L A P A R A I L S L D K W K C N T T D V S V A N G T A E L L H T E H I W Y P R I R E I Q G A I I M S S L I E V V I G L L G L P G A L L K Y I G P L T I T P T V A L I G L S G F Q A A G E R A G K H W G I A M L T I F L V L L F S Q Y A R N V K F P L P I Y K S K K G W T A Y K L Q L F K M F P I I L A I L V S W L L C F I F T V T D V F P P D S T K Y G F Y A R T D A R Q G V L L V A P W F K V P Y P F Q W G L P T V S A A G V I G M L S A V V A S I I E S I G D Y Y A C A R L S C A P P P P I H A I N R G I F V E G L S C V L D G I F G T G N G S T S S S P N I G V L G I T K V G S R R V I Q C G A A L M L A L G M I G K F S A L F A S L P D P V L G A L F C T L F G M I T A V G L S N L Q F I D L N S S R N L F V L G F S I F F G L V L P S Y L R Q N P L V T G I T G I D Q V L N V L L T T A M F V G G C V A F I L D N T I P G T P E E R G I R K W K K G V G K G N K S L D G M E S Y N L P F G M N I I K K Y R C F S Y L P I S P T F V G Y T W K G L R K S D N S R S S D E D S Q A T G
PTM type	X-N-glycosylation X-O-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC23A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	188
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC23A2 Asparagine 188 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC23A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	196
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC23A2 Asparagine 196 has the potential to affect its expression or activity.
O-glycosylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC23A2			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	10
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC23A2 Serine 10 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC23A2			[3]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	406
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC23A2 Cystine 406 has the potential to affect its expression or activity.
Phosphorylation
Serine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC23A2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	17
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Serine 17 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC23A2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Serine 18 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC23A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	70
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Serine 70 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC23A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	71
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Serine 71 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC23A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	78
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Serine 78 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC23A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	81
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Serine 81 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC23A2			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	617
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Serine 617 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC23A2			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	641
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Serine 641 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC23A2			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	8
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Threonine 8 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC23A2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	19
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Threonine 19 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC23A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	75
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Threonine 75 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC23A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	79
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Threonine 79 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC23A2			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	629
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Threonine 629 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC23A2			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	649
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Threonine 649 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC23A2			[5] , [12]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Tyrosine 23 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC23A2			[13]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	60
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC23A2 Tyrosine 60 has the potential to affect its expression or activity.
Ubiquitination
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC23A2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	11
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC23A2 Lysine 11 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC23A2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	22
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC23A2 Lysine 22 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S23A2_HUMAN)
2	A triarylphosphine-trimethylpiperidine reagent for the one-step derivatization and enrichment of protein post-translational modifications and identification by mass spectrometry. Chem Commun (Camb). 2018 Dec 6;54(98):13790-13793.
3	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
4	Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
5	Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis. Anal Chem. 2017 Sep 5;89(17):9307-9314.
6	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
7	Quantitative Phosphoproteome Analysis of Clostridioides difficile Toxin B Treated Human Epithelial Cells. Front Microbiol. 2018 Dec 17;9:3083.
8	Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy. Proteomics. 2008 May;8(10):2024-34.
9	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
10	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
11	Dysregulation of splicing proteins in head and neck squamous cell carcinoma. Cancer Biol Ther. 2016;17(2):219-29.
12	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
13	Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.
14	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence